Atossa Therapeutics’ (ATOS) Buy Rating Reaffirmed at HC Wainwright
Atossa Therapeutics (NASDAQ:ATOS – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a report released on Wednesday,Benzinga reports. They currently have a $7.00 price objective on the stock. A number of other equities analysts also recently issued reports on ATOS. Ascendiant Capital Markets increased their price target […]
Atossa Therapeutics (NASDAQ:ATOS – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a report released on Wednesday,Benzinga reports. They currently have a $7.00 price objective on the stock. A number of other equities analysts also recently issued reports on ATOS. Ascendiant Capital Markets increased their price target […]
